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Abstract 
Purpose of review 
The aim was to synthesise recent evidence on schizophrenia illness experience 
and outcomes and models of care in low and middle-income countries (LMIC). 
Recent findings 
There is a plurality of explanatory models for psychosis and increasing evidence 
that context influences experiences of stigma. People with schizophrenia in LMIC 
are vulnerable to food insecurity, violence and physical health problems, in 
addition to unmet needs for mental healthcare. Family support may help to 
improve outcomes if present, but caregivers may be overwhelmed by the 
challenges faced. Despite efforts to increase availability, evidence-based care 
remains inaccessible to many people with schizophrenia.  Non-randomised 
evaluations in South Africa and Mexico indicate that psychosocial support groups 
for people with schizophrenia and caregivers may be acceptable and useful. 
Randomised controlled trials in Pakistan and China show that culturally-adapted 
cognitive-behavioural therapy can reduce symptom severity. There is emerging 
evidence that traditional and alternative medicine, such as Tai Chi, may be 
beneficial, but to date most research is of low quality. The challenges of 
biomedical-traditional provider collaborations have been highlighted. 
Evaluations of integrated mental health care in primary care are underway and 
promise to provide vital information about how to scale-up quality care. 
Summary 
Acceptable and effective responses to schizophrenia in LMIC should be cognisant 
of both cultural context and universal concerns. Efforts to enhance the quality of 
family support should be central to models of care. 
Key words 
Schizophrenia, low and middle-income countries, global mental health, mental 
health Gap Action Programme 
Introduction 
The field of global mental health has emerged in the last decade, with the 
primary agenda of scaling up services for people with mental health problems, 
especially in low and middle-income countries (LMIC). Global mental health has 
led the way in setting the research and service priorities for mental disorders 
[1]. Schizophrenia is one of the priority disorders due to its association with high 
levels of disability and premature mortality, human rights violations and loss of 
productivity [2]. There is consensus that in both LMIC and high-income countries 
(HIC) optimal care for schizophrenia comprises 1) A combination of anti-
psychotic medication and psychosocial support and 2) Community-based care 
with access to inpatient care for acute crises [2]. However, a severe shortage of 
mental health specialists means that an estimated 69% of people with 
schizophrenia in LMIC do not access any evidence-based care; referred to as the 
‘treatment gap’ [3]. Family members are typically the main source of support. 
Accordingly, efforts to scale up care focus on delivery by trained non-specialists, 
an approach known as task-sharing. The World Health Organization (WHO) 
mental health Gap Action Programme (mhGAP) represents the most widely 
disseminated model of task-sharing for the treatment of schizophrenia, and 
other priority mental disorders, in primary care [4]. Given their wide availability 
and acceptability for the treatment of mental health problems, collaboration with 
traditional and faith practitioners is also proposed as a promising approach [5].  
 A refined understanding of explanatory models, risk factors, illness course, and 
social impact of schizophrenia is paramount for the development of acceptable 
and effective interventions to address the treatment gap. The notion that people 
with schizophrenia in LMIC experience superior outcomes than those in better-
resourced settings is perhaps the most influential and enduring finding from a 
series of multi-country studies conducted by the WHO [6]. However, some 
commentators have challenged the validity of these findings, highlighting, for 
example, the high mortality rates in LMIC, which could have caused differential 
attrition of severe cases, and the variation in outcomes between LMIC settings [7, 
8]. The aim of this review was to synthesise recent evidence on schizophrenia 
illness explanations, impact and outcomes and the accessibility, feasibility and 
effectiveness of models of care in LMIC.  
Explanations and attitudes 
Recent research has consolidated the rich literature on the ways cultural and 
social settings shape understandings of psychotic symptoms [9, 10].  Qualitative 
work in India, Nigeria and Trinidad found that disruptive behaviours, wandering 
and decline in functioning are more often considered signs of psychosis than 
distorted perceptions and beliefs.  Across settings, psychosis was attributed to 
multiple, sometimes contradictory, causes; whilst supernatural beliefs were 
most prominent, biological factors, substance misuse, and psychosocial factors 
were also important [9]. These findings strengthen the recognition of a plurality 
of explanatory models for psychosis in both HIC and LMIC settings.  
 
The implications of context have also been explored in relation to the content of 
delusions [11], help-seeking behaviour [9, 12], and stigma [10, 13, 14]. Campbell 
et al.’s findings echo the axiom that whilst the form of psychotic symptoms is 
universal, the content is dependent on cultural milieu [11]. In this large 
qualitative study amongst South African Xhosa, the majority of persecutory 
delusions related to bewitchment and were perceived to be caused by the 
jealousy of friends or family [11]. Recent multi-country cross-sectional surveys 
have built on previous findings that supernatural explanatory models for 
schizophrenia tend to be associated with greater self-stigma [13] and public 
stigma [10].  More nuanced accounts have lent support to Yang’s theory that 
‘what matters most’ in any society shapes both the experiences of the 
stigmatised and the behaviours of stigmatisers [15]. Using rich qualitative and 
quantitative data, Koschorke et al. concluded that, in India, caregivers’ 
experience of stigma is underpinned by their own and their relatives’ lack of 
achievement in gendered role expectations relating to marriage, work and social 
standing [14]. They also found a complex relationship between knowledge and 
stigma, concluding that biomedical explanatory models may not be beneficial, 
and may even be harmful, in stigma-reduction efforts [14]. In a cross-sectional 
survey (n=4476) Angermeyer et al. found that amongst members of the public in 
Germany, there was a greater desire for social distance from people with 
schizophrenia in remote relationships, in contrast to Tunisia where social 
distance was desired for family relationships. The authors proposed this was due 
to the importance of family life in Tunisian culture, and the difficulties people 
with schizophrenia therefore face in carrying out the social role ‘that matters 
most’ in this setting [10]. 
 Social and health impact 
New research has broadened our understanding of the ways in which people 
with schizophrenia in LMIC represent a uniquely vulnerable group. In rural 
Ethiopia, 32.5% of people with severe mental disorders had severe household 
food insecurity, compared to 15.9% of comparison households (n= 576)[16]. In a 
small cross-sectional survey (n=77), 75% of women with schizophrenia in a 
Nigerian outpatient clinic had experienced intimate partner violence, with 
around three quarters reporting verbal abuse, half reporting physical abuse and 
a quarter reporting sexual violence [17]. This compares to 3.1% of women in a 
general population sample reporting sexual violence in the last 12 months [18]. 
In a qualitative study in rural Ethiopia, people with schizophrenia were found to 
be commonly physically restrained by family members as a strategy to manage 
the illness in the absence of other support. There was pressure from the wider 
community to restrain in order to protect the individual with schizophrenia and 
local residents [19]. 
 
In an analysis of 2002-2004 World Health Survey data (n= 242,952), significantly 
higher multi-morbidity was observed in people with self-reported psychosis 
(36.0% (95% CI, 32.1–40.2%)) compared to those with no psychotic symptoms 
(11.4% (95% CI, 11.0–11.8%)) across 48 LMICs [20]. Despite lower use of 
second-generation anti-psychotic medications in LMIC compared to HIC, angina 
pectoris was the most commonly reported complaint [20], suggesting a universal 
pattern of physical health problems amongst people with schizophrenia. The 
pooled prevalence of metabolic syndrome in people with schizophrenia across 
14 Indian studies was found to be 29.8%, which is comparable to HIC [21]. Liu et 
al. propose a multi-level model of risk, comprising individual factors, health 
systems and social determinants of health, to explain excess mortality in people 
with schizophrenia across LMIC and HIC [22]. Growing interest in the prevalence 
of underweight in people with schizophrenia [23], given the known association 
between underweight and excess mortality in the general population [24] , may 
have particular relevance for LMIC.  
 
 
Risk factors and illness course 
The apparently superior schizophrenia outcomes in LMIC have been 
hypothesised to arise from better social support. Indirect support for this notion 
comes from three recent papers of the 14-year outcomes of the Chengdu Mental 
Health Project cohort study of schizophrenia set in rural Southwest China 
(n=510) [25-27]. Individuals who were either unmarried or had no family 
caregiver at baseline had higher rates of homelessness and suicide, and a lower 
rate of survival after 14 years of follow-up [25, 26].  Individuals with family 
caregivers also had significantly higher functioning scores, lower symptoms 
scores and lower relapse rates at 14 years [25]. However, the study recruited 
prevalent cases, meaning that poorer outcomes may predate baseline data 
collection; hence a causal relationship cannot be confirmed. Furthermore, it is 
established globally that it is not simply the presence but the nature of family 
support that influences outcomes. In common with findings across LMIC and HIC 
settings, a recent study in Pakistan (n=53) found the relapse rate for people with 
schizophrenia in high-expressed emotion households was 72% as compared 
with 36% in low-expressed households (p= <0.05) [28]. 
 
Two small-scale but in-depth qualitative papers from South Africa contest some 
assumptions around the nature of informal care for people with schizophrenia in 
LMIC. Whilst care was readily and flexibly provided by family and community 
members in most cases [29], this was often because they felt obligated to do so 
[30]. One study found that family members used non-confrontational care 
strategies, including unrestricted mobility, to avoid conflict with care recipients 
[29]. These findings contrast with the restrictive practices, including restraint, 
identified as part of informal care in other settings [19]. Gaps and difficulties 
were also identified: informal care was sometimes not available due to caregiver 
employment, sickness or death [29] and caregivers experienced substantial 
obstacles in supporting medication adherence, especially in the context of 
violence, food insecurity and substance abuse [30].  
 
Recent exploratory research has proposed universal mechanisms for the 
development of psychotic symptoms and further challenged the notion of a more 
supportive family environment in LMIC. An online community-based survey in 
Chile, Columbia, Indonesia, Germany and US found that, whilst participants from 
LMIC were more likely to report that they had any family support, they also 
perceived more criticism compared to participants from HIC (n=1317). 
Moreover, the association between criticism and psychosis proneness was 
stronger in LMIC compared to HIC [31]. Jaya et al. used cross-sectional survey 
data (n=2350) to demonstrate that cognitive vulnerability, particularly negative 
schemas, mediates the relationship between social adversity and self-reported 
psychotic symptoms in a similar way in the US, Germany and Indonesia [32]. 
These findings, and similar recent papers [33], are amongst the first to explore 
cognitive models of psychosis in LMIC and may have important implications for 
the use of cognitive therapies across cultural contexts. 
 
Models of evidence-based care and access to care 
 A systematic review identified 33 papers relating to mhGAP implementation in 
LMIC across disorders, including training evaluations and country 
contexualisations [4], demonstrating the importance of mhGAP for global mental 
health practitioners and researchers. There are indications that care delivered 
by primary healthcare workers can support clinical improvements in people 
with schizophrenia but most studies to date, such as a 12-month cohort study in 
Nepal, have been small (n=85) and non-randomised [34]. The forthcoming 
results of more rigorous evaluations, including the TASCs non-inferiority RCT in 
rural Ethiopia [35] and the five-country Programme for Improving Mental 
healthcarE treatment cohorts and facility detection studies [36], promise to shed 
more light on the impact of the mhGAP model.  
 
It is increasingly recognised that alongside improved availability, services must 
be of high quality to achieve improved patient outcomes [37]. Reflecting growing 
efforts to consult people with schizophrenia in service design, Mayston et al. 
developed and validated the Mental Health Service Satisfaction Scale for rural 
Ethiopia [37, 38].  Given the limited coverage of community-based services, 
psychiatric hospitals remain an important source of care for people with 
schizophrenia in LMIC, particularly for those who are destitute [39]. The WHO 
QualityRights initiative aims to improve human rights conditions in mental 
health facilities [40], though evaluations of the impact of such initiatives have so 
far been of low quality [41].  A new multi-level model for interventions to reduce 
excess mortality in persons with severe mental disorders, comprising individual, 
health system, community and policy-level interventions, can be readily applied 
to both LMIC and HICs [22]. However, implementation and evaluation of such 
interventions in LMIC is limited to date. 
 
There is mounting recognition that even where biomedical services are available, 
people with schizophrenia may not access treatment. Descriptions of service 
utilisation have tended to assume that biomedical care is the ‘final destination’ in 
the treatment journey [42].  Labys et al. consulted 83 stakeholders (traditional 
healers, religious leaders and caregivers) in rural KwaZulu Natal, South Africa, to 
gain richer insights into patterns of help-seeking [12]. Nearly half of the people 
with psychosis discussed had never accessed biomedical care, whilst half had 
accessed a traditional healer. In some cases care was sought in parallel. In 
qualitative studies in Ethiopia and Tanzania, people with schizophrenia, 
caregivers and healthcare workers reported substantial barriers to engagement 
with care [43, 44]. In both settings there were erratic anti-psychotic medication 
supplies and difficulties paying for medication, due to poverty. In Tanzania 
whilst free mental health services are mandated, this is not usually the case in 
practice [44]. Other reasons for disengagement were the long illness course and 
unmet expectations of cure. Differing explanatory models were rarely noted as 
reasons for disengagement [43]. 
 
Psychosocial interventions 
Previous research has demonstrated the benefits of family and psychosocial 
interventions for people with schizophrenia in LMIC, particularly in China [45]. 
Current developments include a greater emphasis on feasibility, such as delivery 
by non-specialists [46, 47] and peers [48], and a growing interest in 
rehabilitation-focused interventions [46, 47]. Using a pretest-posttest design, a 
12-week family-to-family psychoeducation intervention in Mexico City produced 
small reductions in expressed emotion amongst caregivers of people with 
schizophrenia (n=230 family members) [48]. In Jordan, Al Hadihasan et al. found 
that even an extremely low-intensity intervention comprising psychoeducational 
leaflets with follow-up phone calls is acceptable and may impact on patient 
outcomes through improving knowledge, coping skills and self-confidence [49]. 
Participants in a pilot of group psychosocial rehabilitation in South Africa 
likewise reported improvements in knowledge and self-esteem, and also social 
support and self-care. However, a substantial acceptability issue was the absence 
of income-generating opportunities [46]. Delivery by auxiliary social workers, a 
non-specialist cadre, was found to be feasible [46]. Results from the 
Rehabilitation Intervention for people with Schizophrenia in Ethiopia cluster-
randomised trial, will provide insights into the effectiveness of community-based 
rehabilitation delivered by lay health workers [47]. 
 mHealth approaches offer exciting scope for intervention scalability. An RCT in 
rural China will evaluate the effectiveness of a multicomponent intervention 
comprising medication reminders via mobile text and voice messaging, an award 
system to incentivise medication adherence and support for family members 
[50]. A pilot study set in Cape Town assessed the feasibility of a single 
psychoeducation session and text message appointment reminders amongst 
people with severe mental illness (n=77). Substantial problems were identified; 
41.2% did not receive the text messages as phones were lost, stolen or numbers 
were changed [51]. Although it was not explored in this paper, it is conceivable 
that difficulties using electronic devices may disproportionately affect the 
poorest. This pilot therefore highlights that an unintended negative consequence 
of mHealth interventions may be to widen health inequalities. 
 
A recent RCT has demonstrated the effectiveness of brief culturally-adapted CBT 
delivered by community clinicians in improving outcomes in people with 
schizophrenia in China. Guo et al. found a clinically significant improvement in 
symptoms in 37.3% in the CBT plus treatment as usual (TAU) arm vs 19.1% in 
TAU alone arm (p=0.003)[52]. RCTs in Pakistan and China also demonstrated the 
effectiveness of CBT delivered by psychiatrists and psychologists in hospital 
settings [53, 54]. Qualitative studies in China and Pakistan have explored 
potential cultural adaptations to CBT for non-Western settings, including a bio-
psycho-spiritual-social model for conceptualising and managing psychosis and 
the close involvement of family members [55, 56]. 
 
Traditional, faith and alternative medicine 
Nortje et al.’s systematic review examined evidence for the effectiveness of any 
type of traditional healing (including holy water and herbal remedies) across 
HICs and LMICs. Evaluations were generally of poor quality, included mixed 
psychiatric diagnoses, and utilised non-randomised designs [57].  The authors 
concluded that whilst acute relapses of schizophrenia may improve whilst 
individuals are under the care of traditional healers, these improvements cannot 
be distinguished from the natural illness course. One included study indicated an 
association between religious healing and relapse, though reverse causality 
could not be ruled out [57]. A large effect of adjunctive Tai Chi on negative 
symptoms of schizophrenia (five RCTs; n=451) was found in a systematic review 
and meta-analysis (Standardised Mean Difference 0.87 (95% CI -1.51, -0.24), 
p=0.007) [58].  A Cochrane Review concluded Wendan decoction (a Chinese herb 
formula) may produce short-term improvements in psychotic symptoms 
compared to placebo, and whilst the formula is no better than anti-psychotic 
medication in improving mental state it has fewer side effects [59]. However, the 
quality of evidence was low in both reviews [58, 59]. 
 
There are few evaluations of biomedical-traditional provider collaborations. Van 
der Watt’s qualitative study provides fascinating insights into the views of 
biomedical and alternative mental healthcare providers on potential 
collaboration in Ghana, Kenya and Nigeria [60]. Several barriers were identified, 
including a mutually strong sense of distrust towards, and superiority over, the 
other provider groups. The incompatibly of different belief systems and the 
perceived intention of biomedical providers to siphon expertise from traditional 
healers without acknowledgement or compensation, were also cited [60]. The 
COllaborative Shared care to Improve Psychosis Outcome RCT will compare the 
effectiveness of a collaborative care programme with usual care at improving 
symptom severity in people with psychosis in Nigeria and Ghana [61]. 
Conclusion 
Social and cultural contexts continue, rightly, to be considered important forces 
shaping the illness experience of schizophrenia. Yet there is increasing 
appreciation of universal influences on schizophrenia outcomes and the 
problems associated with the illness, such as physical co-morbidities. Acceptable 
and effective responses to schizophrenia in LMIC should be cognisant of both 
sets of factors. Efforts to enhance the quality of family support should also be 
central to models of care, given the influence of the family in outcomes, and their 
typical role as primary care provider. Learning in this area may have wider 
relevance to HIC. Alternative treatment approaches such as Tai Chi may be a 
vehicle for the shift of global mental health from ‘delivery science to discovery 
science’ [62]. Some topics have received little attention in LMIC including 
involuntary treatment, early intervention and how to address excess mortality. 
The evolution of global mental health into a truly global discipline will benefit 
people with schizophrenia in low, middle and high-income country settings [62].  
Key points 
o There is a plurality of explanatory models for psychosis across settings 
and context influences experiences of stigma. People with schizophrenia 
in LMIC are vulnerable to food insecurity, violence and physical health 
problems. 
o Being married or having close family may be associated with better 
outcomes in LMIC. However social support is not always available and 
caregiving is challenging.  
o Evidence-based care remains inaccessible to many people with 
schizophrenia. Psychosocial support groups appear to be acceptable and 
culturally-adapted cognitive-behavioural therapy can reduce symptom 
severity.  
o Most research on traditional and alternative treatments for schizophrenia 
is of low quality, but some modalities, such as Tai Chi, may be beneficial. 
The challenges of biomedical-traditional provider collaborations have 
been highlighted and forthcoming evaluations will evaluate their 
effectiveness. 
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